Author Correction to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease

1 Author Correction to: CNS Drugs https://doi.org/10.1007/s40263-018-0498-4

An Online First version of this article was made available online at http://link.springer.com/journal/40263/onlineFirst/page/1 on 12 March 2018. An error was subsequently identified in the article, and the following correction should be noted:

Table 2, Primary efficacy results for the phase III studies and pooled populations at week 12: in the ‘Pooled’ section of the table, the ‘Placebo’ and ‘ADS-5102’ column headings are transposed. The corrected table is shown in the following page.

The original article has been corrected.

Table 2 Primary efficacy results for the phase III studies and pooled populations at week 12